Form 4 for PYXS Pyxis Oncology, Inc.
Accepted 2026-03-25 00:00:00 ET · period of report 2026-03-24 · accession 0001193125-26-124380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-25 | 2026-03-24 | PYXS | Wadhane Jitendra | Prin Fin, Acct Off | A - Grant | $0.00 | +109.5K | 512.9K | +27% | $0 |
| D | 2026-03-25 | 2026-03-24 | PYXS | Wadhane Jitendra | Prin Fin, Acct Off | A - Grant | $0.00 | +262.6K | 262.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-24 | A | A | 109,461 | $0.00 | 512,882 | D | — | — | (F1) Represents restricted stock units that vest 25% on March 31, 2026, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-03-24 | A | A | 262,635 | $0.00 | 262,635 | D | $1.36 · — to 2036-03-24 | 262,635 Common Stock | (F2) The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 24, 2026 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued emmployment through the applicable vesting date. |